Of the three marijuana-based drugs that have been approved by the FDA to date, none have been big commercial successes. In contrast, this cannabinoid drug, which appears to be nearing FDA approval, is expected to be one of the 10 biggest new drugs launched this year. Here’s what investors need to know – including whether medical marijuana poses a threat to its success. CLICK HERE.
Blockbuster Or Bust?
- by Ashley Hayes
Tags:Annabinoid DrugFDAInvestmentInvestment StrategyInvestorMarijuana InvestmentMarijuana-Based DrugsMedical Marijuana InvestingMMJ InvestingMMJ StocksStock Market